Wincanton PLC
29 October 2004
29 October 2004
Wincanton Plc
Wincanton and GlaxoSmithKline Seal 10-Year Partnership
Wincanton Plc ('Wincanton'), one of Europe's leading providers of supply chain
solutions, today announces it has secured a contract with GlaxoSmithKline ('GSK
') to support the future growth of the Consumer and Nutritional Healthcare
business and develop its supply chain infrastructure. The 10-year contract is
the biggest to be awarded in the industry this year. It builds on Wincanton's
existing long-term relationship with GSK by specifying the design and operation
of a new 34100m2 automated distribution centre in Middlewich, Cheshire. The new
arrangement also consolidates and extends the term of existing contracts at
Brockworth, Gloucestershire.
The reorganisation of GSK's supply chain has been triggered by strong growth in
the consumer and nutritional healthcare markets over the past five years. Now, a
second automated facility is required to increase GSK's capacity, maximise
throughput and create a northern operational base in anticipation of the
impending Working Time Directive (WTD).
Brian Kennedy, GSK Customer Services Director for the Consumer and Nutritional
Healthcare business said: 'The new distribution centre will replicate the
successful Brockworth operation. By opening a new base in the north we are able
to accommodate future growth and can also create a more logical footprint for
the UK supply chain ahead of the impending WTD. The Middlewich operation will
also enable us to work better within the new driver hours structure and maximise
vehicle utilisation.'
Commenting on the win, Jeff Anderson, Managing Director, Manufacturing at
Wincanton said: 'Our relationship with GSK has continued to evolve because of
our proactive approach and commitment to continuous improvement. The fact that
we have been awarded the Middlewich contract underlines our continuing
investment in automation as a business and reinforces Wincanton's market leading
position. Our experience and reputation in automated warehousing has been built
up over the past 10 years through contracts with a range of retail and
manufacturing customers, managing a total of 11 automated facilities.'
Wincanton's partnership with GSK began in 1998 with the construction of the
Brockworth automated National Distribution Centre. Most recently, Wincanton also
took on the management of GSK's field aligned customer service teams.
Significant success has been achieved in the extension of the existing logistics
partnership into added value services.
For further enquiries please contact:
Wincanton plc
Paul Bateman, Chief Executive Tel: 01963 828282
Gerard Connell, Group Finance Director
Buchanan Communications Ltd Tel: 020 7466 5000
Charles Ryland, Jeremy Garcia
Editors' notes
Wincanton plc - delivering supply chain solutions
Wincanton plc is a leading provider of supply chain solutions and ranks third in
Europe and second in the UK. It designs, implements and operates creative
solutions for rigorous and frequently complex customer demands in 15 countries.
The business has a turnover of over €2.4bn / £1.68bn and employs 25,000 staff
across 360 locations.
The business is built on long-term partnerships with customers in a broad range
of industries. Wincanton provides substantial customer benefits in improved
efficiencies and cost savings. Customers include many of the biggest global
names in sectors that include automotive, FMCG, retail, petrochemical and
manufacturers of all types.
Warehousing solutions are tailored to requirements on a dedicated, shared-user
or networked basis. Transport is provided utilising road, rail, air and
water-based systems. Specialist added value services include reverse supply
chain programmes, recycling operations, 4PL, data records management and supply
chain consultancy. Further information on Wincanton's unique achievements and
competencies can be found by visiting www.wincanton.co.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.